Paul Stahls, MD
Clinical Cardiac Electrophysiology · Covington, LANPI 1508057530
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 23.4%. Reporting peaked in 2019 at $5,075 and has fallen 51.4% since, to $2,465 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in LA, where the typical reported total is $18,132.
Across 270 payments — averaging $65.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$4K
- Abbott$4K
- Biotronik Inc.$3K
- Cardiofocus, Inc.$1K
- Medtronic$1K
- Boston Scientific$1K
- plus $3K from 26 others
What the payments were for
- Speaking & faculty fees$4,09523%
- Travel & lodging$3,91022%
- Food & beverage$9,68355%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 6 | $4,131 |
| Abbott | 109 | $3,932 |
| Biotronik Inc. | 22 | $2,810 |
| Cardiofocus, Inc. | 12 | $1,453 |
| Medtronic(2 entities) | 27 | $1,404 |
| Boston Scientific | 23 | $1,139 |
| Kestra Medical Technology Services, Inc. | 14 | $831 |
| AstraZeneca | 3 | $235 |
| Angiodynamics, Inc. | 1 | $200 |
| Abiomed | 3 | $165 |
| Pfizer | 5 | $152 |
| Impulse Dynamics (USA) Inc. | 2 | $149 |
| Inspire Medical Systems, Inc. | 2 | $143 |
| Philips North America LLC | 5 | $139 |
| Novartis | 4 | $137 |
| Baxter Healthcare | 4 | $116 |
| E.r. Squibb & Sons, L.L.C. | 5 | $97 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $56 |
| Alnylam Pharmaceuticals Inc. | 2 | $44 |
| Davol Inc. | 1 | $43 |
| Sanofi-aventis U.S. LLC | 2 | $41 |
| Esperion Therapeutics, Inc. | 3 | $39 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $38 |
| Contego Medical, Inc | 1 | $29 |
| Johnson & Johnson | 2 | $27 |
| Novo Nordisk | 1 | $23 |
| Lundbeck LLC | 1 | $23 |
| Exact Sciences | 1 | $22 |
| Cardiva Medical, Inc. | 1 | $20 |
| Terumo Medical Corporation | 1 | $19 |
| Bayer | 1 | $19 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRADAXA$4,095
- HeartLight System$1,232
- AMPLATZER AMULET$773
- Acticor 7 VR-T DX$675
- AVEIR$538
- Assure WCD$485
- RESONATE EL ICD VR$405
- LINQ II$277
- WATCHMAN Access System$262
- BioMonitor$257
- Solia$257
- AMVIA EDGE$257
- Selectra$257
- JOT DX$226
- FARXIGA$223
- Auryon Laser System 100-120 Vac$200
- AMPLATZER$159
- VIEWMATE$136
- Abre$131
- Evera$123
How this compares
$17,688 in reported general payments places this provider in the 45th percentile of 43 clinical cardiac electrophysiology providers in Louisiana.
See all clinical cardiac electrophysiology providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 315 | $310,000 |
| EntrestoSacubitril/Valsartan | 118 | $125,393 |
| XareltoRivaroxaban | 44 | $54,396 |
| Repatha SureclickEvolocumab | 59 | $42,842 |
| FarxigaDapagliflozin Propanediol | 44 | $38,249 |
| Dofetilide | 40 | $12,420 |
| JardianceEmpagliflozin | 12 | $6,904 |
| Praluent PenAlirocumab | 13 | $6,287 |
| Amiodarone Hcl | 150 | $5,099 |
| Verapamil SrVerapamil Hcl | 29 | $2,832 |
| Metoprolol Succinate | 198 | $2,673 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 98 | $2,656 |
| Flecainide Acetate | 78 | $2,247 |
| ClopidogrelClopidogrel Bisulfate | 202 | $2,124 |
| Carvedilol | 202 | $1,685 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $152 | $310,000315 claims |
| NovartisEntresto | $137 | $125,393118 claims |
| Johnson & JohnsonXarelto | $27 | $54,39644 claims |
| AstraZenecaFarxiga | $235 | $38,24944 claims |
| Boehringer IngelheimJardiance | $4,131 | $6,90412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 43 clinical cardiac electrophysiology providers in Louisiana.
Other clinical cardiac electrophysiology in Covington
- Nassir MarroucheNew Orleans$498K
- Sammy KhatibNew Orleans$115K
- Paul LelorierNew Orleans$101K
- Adil YousufNew Orleans$101K
- Mark PolletBaton Rouge$90K
- Joshua AymondBaton Rouge$64K
- Michael BernardNew Orleans$59K
- Dedric ClarkeNew Orleans$51K
- Eoin DonnellanLafayette$48K
- Glenn PolinNew Orleans$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.